Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to $151993.0.

  • Coeptis Therapeutics Holdings' Other Non Operating Income fell 5651.13% to $151993.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$651838.0, marking a year-over-year decrease of 70355.37%. This contributed to the annual value of -$341660.0 for FY2024, which is 16017.79% down from last year.
  • Coeptis Therapeutics Holdings' Other Non Operating Income amounted to $151993.0 in Q3 2025, which was down 5651.13% from -$338460.0 recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Other Non Operating Income peaked at $2.3 million during Q4 2022, and registered a low of -$3.4 million during Q1 2022.
  • Over the past 4 years, Coeptis Therapeutics Holdings' median Other Non Operating Income value was $15017.0 (recorded in 2022), while the average stood at -$4590.6.
  • The largest annual percentage gain for Coeptis Therapeutics Holdings' Other Non Operating Income in the last 5 years was 24740000.0% (2024), contrasted with its biggest fall of 22245.14% (2024).
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Other Non Operating Income stood at $2.3 million in 2022, then crashed by 107.89% to -$178875.0 in 2023, then tumbled by 222.45% to -$576785.0 in 2024, then soared by 126.35% to $151993.0 in 2025.
  • Its Other Non Operating Income stands at $151993.0 for Q3 2025, versus -$338460.0 for Q2 2025 and $111414.0 for Q1 2025.